Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Richards

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
Nephron. Experimental Nephrology|August 18, 2009
Pathogenesis of thrombotic microangiopathy: insights from animal modelsAnna Richards, David Kavanagh
Immunobiology|August 23, 2011
Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndromeHeather Kerr, Anna Richards
Annual Review of Medicine|August 21, 2007
Complement regulatory genes and hemolytic uremic syndromesDavid Kavanagh, Anna Richards, John Atkinson
Seminars in Nephrology|October 29, 2013
Atypical hemolytic uremic syndromeDavid Kavanagh, Tim H Goodship, Anna Richards
Advances in Immunology|November 6, 2007
Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degenerationAnna Richards, David Kavanagh, John P Atkinson
Seminars in Thrombosis and Hemostasis|September 25, 2010
Transplantation in atypical hemolytic uremic syndromeDavid Kavanagh, Anna Richards, Tim Goodship, et al.
British Medical Bulletin|September 14, 2006
Atypical haemolytic uraemic syndromeDavid Kavanagh, Timothy H J Goodship, Anna Richards
Current Opinion in Nephrology and Hypertension|July 10, 2002
The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpuraAnna Richards, Judith A Goodship, Timothy H J Goodship
BMJ (Clinical Research Ed.)|June 5, 2012
Beware renal adverse effects of anti-vascular endothelial growth factor treatmentLindsay Keir, Feike van Moorsel, Moin A Saleem, et al.
Protein Expression and Purification|December 15, 2010
Production of biologically active complement factor H in therapeutically useful quantitiesChristoph Q Schmidt, Fern C Slingsby, Anna Richards, et al.
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
Nephron. Experimental Nephrology|August 18, 2009
Pathogenesis of thrombotic microangiopathy: insights from animal modelsAnna Richards, David Kavanagh
Immunobiology|August 23, 2011
Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndromeHeather Kerr, Anna Richards
Annual Review of Medicine|August 21, 2007
Complement regulatory genes and hemolytic uremic syndromesDavid Kavanagh, Anna Richards, John Atkinson
Seminars in Nephrology|October 29, 2013
Atypical hemolytic uremic syndromeDavid Kavanagh, Tim H Goodship, Anna Richards
Advances in Immunology|November 6, 2007
Inherited complement regulatory protein deficiency predisposes to human disease in acute injury and chronic inflammatory statesthe examples of vascular damage in atypical hemolytic uremic syndrome and debris accumulation in age-related macular degenerationAnna Richards, David Kavanagh, John P Atkinson
Seminars in Thrombosis and Hemostasis|September 25, 2010
Transplantation in atypical hemolytic uremic syndromeDavid Kavanagh, Anna Richards, Tim Goodship, et al.
British Medical Bulletin|September 14, 2006
Atypical haemolytic uraemic syndromeDavid Kavanagh, Timothy H J Goodship, Anna Richards
Current Opinion in Nephrology and Hypertension|July 10, 2002
The genetics and pathogenesis of haemolytic uraemic syndrome and thrombotic thrombocytopenic purpuraAnna Richards, Judith A Goodship, Timothy H J Goodship
BMJ (Clinical Research Ed.)|June 5, 2012
Beware renal adverse effects of anti-vascular endothelial growth factor treatmentLindsay Keir, Feike van Moorsel, Moin A Saleem, et al.
Protein Expression and Purification|December 15, 2010
Production of biologically active complement factor H in therapeutically useful quantitiesChristoph Q Schmidt, Fern C Slingsby, Anna Richards, et al.
Pageof 5